Similar Items: And therapeutic outcomes lopinavir-ritonavir and a rifampicin containing anti-tuberculosis pharmacokinetics in children with tuberculosis/hiv co-infection treated with regimen
- Pharmacokinetic-Pharmacogenetic-and-Pharmacodynamic Adherence Relationships in Cohort South African HIV Infected Children on Lopinavir-and Nevirapine-Based Regimens
- Lopinavir/ Ritonavir, an Antiretroviral Drug, Lowers Sperm Quality and Induces Testicular Oxidative Damage in Rats
- Drug repurposing and optimisation to improve tuberculosis treatment
- Population pharmacokinetic modelling to optimise treatment for children with Rifampicin-resistant TB and HIV
- The prevalence of isoniazid and rifampicin resistance of Mycobacterium tuberculosis
- Addressing critical knowledge gaps to improve and shorten multidrug-resistant tuberculosis treatment regimens in children
Author: Cotton, Mark F.
- The relevance of apoptosis in the pathogenesis of human immunodeficiency virus-1 disease
- Social and contextual factors affecting HIV-infected women’s feeding practices for their infants in normal practice settings : effects on growth and morbidity
- Neuro-imaging in paediatric HIV, a MRI/DTI study
- The neurodevelopmental outcomes of perinatally HIV-infected children on different antiretroviral treatment (ART) strategies
- And therapeutic outcomes lopinavir-ritonavir and a rifampicin containing anti-tuberculosis pharmacokinetics in children with tuberculosis/hiv co-infection treated with regimen
- Lipoatrophy in HIV-infected children on antiretroviral therapy
Author: Rabie, Helena
- Antibiotic use profile in a South African paediatric intensive care unit: A Prospective cohort description
- Short-term outcomes of children with multisystem inflammatory syndrome in children (MIS-C) in South Africa : a prospective cohort study
- Outcomes of children with acute myocarditis and dilated cardiomyopathy admitted to a tertiary hospital in the Western Cape south africa: an 8 year study
- A profile of the prevention of mother-to-child transmission (pMTCT) and clinical status of HIV-infected children younger than 18 months admitted to Tygerberg Hospital over a one-year period
- And therapeutic outcomes lopinavir-ritonavir and a rifampicin containing anti-tuberculosis pharmacokinetics in children with tuberculosis/hiv co-infection treated with regimen